Abstract:Amyloids are insoluble fibrillar protein aggregates. While they are commonly found in human diseases, it is becoming increasingly clear that this type of structure is essential for a range of biological functions, with prominent examples in organisms ranging from bacteria to human. Functional amyloid and pathogenic amyloid share similar physical and chemical properties. Unlike pathological amyloids, however, the structures of functional amyloids are formed by polypeptide sequences whose amyloid structure has been under a positive evolutionary selection pressure. This important distinction provides us with an opportunity to obtain structural insights from an unexpected source: the covariation of amino acids among sequences within the same family of a functional amyloid protein. There is a long history for the idea of using coevolution for molecular structure prediction, but recent growth in sequence databases and new, efficient algorithms to disentangle indirect couplings in a network, have dramatically improved our ability to predict residue-residue contacts. We used recently developed sequence analysis methods (EVcoupling, PSICOV and GREMLIN) to extract distance restraints from a multiple sequence alignment of a functional amyloid protein. Together with an efficient force field, these restraints allow us to determine atomic resolution structural models. We find that the protein forms a beta-helical structure, where each turn corresponds to previously identified repeat sequences. The proposed structure is validated by previously published solid-state NMR, electron microscopy and X-ray diffraction data, and confirms an earlier proposed model derived by complementary means. To our knowledge, this is the first time the analysis of correlated mutations and computer simulations have been used together to study the structure of a functional amyloid. The current study therefore serves as a probe into the potential applicability of the approach in this domain.

Designed peptides that assemble into cross-alpha amyloid-like structures.

Designed Peptides That Assemble into Cross-Α Amyloid-Like Structures

Tuning Self-Assembled Morphology of the Aβ(16-22) Peptide by Substitution of Phenylalanine Residues.

De Novo Design of Cross-α Amyloid-Like Fibrils with Cellular Activity

Self-assembly of Short Aβ(16-22) Peptides: Effect of Terminal Capping and the Role of Electrostatic Interaction.

Identification of a Novel Parallel Β‐strand Conformation Within Molecular Monolayer of Amyloid Peptide

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

What Does Evolution Tell Us About The Structure Of A Functional Amyloid Protein?

Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)

De Novo Design of Self-Assembled Hexapeptides As Β-Amyloid (aβ) Peptide Inhibitors.

A Novel Form of Beta-Strand Assembly Observed in A Beta(33-42) Adsorbed Onto Graphene

Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.

De novo Design of Peptides that Bind Specific Conformers of α-Synuclein

Design of amyloidogenic peptide traps

In situ AFM investigation of dual-mode self-assembling peptide

Hierarchical Self-Assembly of a Β-Amyloid Peptide Derivative.

De novo designed aliphatic and aromatic peptides assemble into amyloid-like cytotoxic supramolecular nanofibrils

Design of parallel 𝛽-sheet nanofibrils using Monte Carlo search, coarse-grained simulations, and experimental testing

Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly

Co-Assembly Induced Transformation of Dipeptide Amyloid-Like Structures into Stimuli-Responsive Supramolecular Materials.

Competition between crystal and fibril formation in molecular mutations of amyloidogenic peptides